AYJANAH MOORE: Open Payments
NPI 1871908095 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 11 payments from 6 companies in 2025. Trend: 2023 $180 · 2024 $337 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $17 |
Products named: REXULTI, INVEGA SUSTENNA, INGREZZA, HETLIOZ, Auvelity, WELLBUTRIN, ABILIFY MAINTENA.
Industry payments across GA — which companies pay providers there.
